Cardiol Therapeutics (Form 6-K Summary)

Filing Date: November 5, 2025

The primary material event reported concerns clinical trial updates:

• Key Event: Cardiol Therapeutics announced results from its Phase II ARCHER Trial.
• Presentation: These trial results are scheduled for presentation at the upcoming European Society of Cardiology Scientific Meeting focusing on Myocardial & Pericardial Diseases.

This filing signals a potential milestone regarding clinical data readout validation by a major cardiology society, which is crucial for future drug development and invest